NovaBridge Biosciences
NBPNasdaqHealthcare · Pharmaceutical Preparations · E9 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Cbc Investment I-Mab LtdActivist (13D)Feb 3, 2026
- Everest Medicines LtdActivist (13D)Aug 5, 2025
- Infini Capital Management LtdPassive (13G)Feb 6, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 4.9M | 4.6 | +19.6% |
| Apr 30, 2026 | 4.1M | 3.4 | -4.7% |
| Apr 15, 2026 | 4.3M | 4.8 | -14.8% |
| Mar 31, 2026 | 5.1M | 5.2 | -6.6% |
| Mar 13, 2026 | 5.4M | 5.9 | -1.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.